CLINICAL_TRIALS
trial_result
· 2015-10-05
Clinical Trial Update: Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis [Phase 2]
Summary
Phase 2 dose-ranging study of oral viscous budesonide in pediatric patients with eosinophilic esophagitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Eosinophilic Esophagitis (EoE) | Phase 2 | Status: COMPLETED | Results posted: 2015-10-05